The reverse split does not alter the company's underlying business or financial health. Monitor for upcoming earnings report to assess fundamental trends; the reduced float may introduce temporary volatility but provides no directional catalyst.
Price Chart
Executive Summary
BIO-key implemented a 1-for-10 reverse stock split effective April 29, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The split reduces outstanding shares from ~10.85M to ~1.085M, with no fractional shares issued. No financial data or strategic changes accompany this purely mechanical action.
Key Facts
- Reverse stock split ratio set at 1-for-10, effective 5:00 p.m. ET on April 29, 2026.
- Outstanding shares reduced from approximately 10,852,118 to approximately 1,085,212.
- No fractional shares; fractional shares rounded up to nearest whole share.
- Authorized shares and par value remain unchanged.
- Split intended to help regain compliance with Nasdaq's $1.00 minimum bid price requirement.
Financial Impact
No financial figures reported; split does not change aggregate market cap or fundamentals.
Risk Factors
- Reverse split signals ongoing financial distress and low stock price.
- Going concern risk persists given history of losses and limited revenue.
- Potential future dilutive offerings if capital needs remain unmet.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-013905 |
| Exhibit: ex_952849.htm | 0001437749-26-013905 |
| Exhibit: ex_952848.htm | 0001437749-26-013905 |
| Document: 0001437749-26-013905-index-headers.html | 0001437749-26-013905 |
| Document: 0001437749-26-013905-index.html | 0001437749-26-013905 |
| Document: 0001437749-26-013905.txt | 0001437749-26-013905 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 16d ago | S-1 | $1.65 | awaiting T+60 | — | $2.86 (−73.03%) |
Oct 6, 2026 19d ago | DEFA14A | $1.76 | awaiting T+60 | — | $2.86 (+62.22%) |
Oct 6, 2026 19d ago | 8-K | $1.76 | awaiting T+60 | — | $2.86 (+62.22%) |
Oct 2, 2026 23d ago | 8-K | $1.93 | awaiting T+60 | — | $2.86 (−47.93%) |
Sep 29, 2026 27d ago | Press Release | $3.12 | awaiting T+60 | — | $2.86 (−8.49%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | — | $2.86 (+3.87%) |
Aug 14, 2026 10w ago | 8-K | $3.18 | awaiting T+60 | — | $2.86 (+10.22%) |
Aug 13, 2026 10w ago | Press Release | $3.18 | awaiting T+60 | — | $2.86 (−10.22%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | — | $2.86 (−31.53%) |
Jul 28, 2026 12w ago | Press Release | $4.25 $2.10 | ▼ −50.59% | ▼ −54.94% | $2.86 (−32.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers